LDHA and cancer: Moreover, although lactate dehydrogenase-A (LDH-A) was frequently identified as an overexpression gene in human cancers (10), none of the LDH-A inhibitors have reached clinical trials as effective antimetabolite chemotherapy drugs, suggesting either insufficient drug exposure, unacceptable toxicity (11), or a lack of LDH-A dependence in human tumors.